Sort   by:  
 Page size 
UnknownA phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.
Not available
S-EPMC4125701 | biostudies-literature
ModelsClaret2009 - Predicting phase III overall survival in colorectal cancer
Claret2009 - Predicting phase III overall survival in colorectal cancer This model is described in the article: Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics. Claret L, Girard P, Hoff PM, Van Cutsem E, Zuide...
2017-08-31 | MODEL1708310001 | BioModels
UnknownPhase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy.
Not available
S-EPMC8478140 | biostudies-literature
UnknownPhase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas.
Not available
S-EPMC4544571 | biostudies-literature
UnknownPhase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.
Not available
S-EPMC2815707 | biostudies-literature
UnknownPharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer.
Not available
S-EPMC6682857 | biostudies-literature
UnknownCirculating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy.
Not available
S-EPMC7764102 | biostudies-literature
UnknownImmune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 study.
Not available
S-EPMC12496205 | biostudies-literature
UnknownPregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial.
Not available
S-EPMC5634769 | biostudies-literature
UnknownEvaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer.
Not available
S-EPMC6755539 | biostudies-literature
Sort   by:  
 Page size